Clinical

Dataset Information

A double-blind, controlled trial to evaluate the efficacy and safety of vitamin K1 ointment for cetuximab and Panitumumab-induced acneiform eruption


ABSTRACT: Interventions: 0.1% vitamin K1 ointment twice daily Placebo ointment twice daily Primary outcome(s): The number of acneiform eruptions of right and left lesions(face, neck, or chest) of the same patient before and after treatment Study Design: Parallel Randomized

DISEASE(S): Colorectal Cancer

PROVIDER: 2623509 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR